Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to welcome two experienced senior leaders to its Finance team – Christopher Jenkins, Vice President of Financial Planning & Analysis and Tara Lambert, Vice President & Controller, Accounting.
FCS takes exception to a recent study published suggesting that colonoscopies are not as effective at preventing colorectal cancer deaths as previously thought.
Florida Cancer Specialists & Research Institute, LLC (FCS) celebrated the groundbreaking for its new clinical site location in Davenport, FL, yesterday. The new clinic will be located at 2050 Holly Hill Fruit Rd., Davenport, FL. 33837, and will boast nearly 15,000 square feet and offer a broad range of treatments and services for patients with cancer and blood disorders, including medical oncology/hematology, infusions, radiology, an in-house laboratory and pharmacy, and care management services.
Florida Cancer Specialists & Research Institute, LLC (FCS) medical oncologist Scott Tetreault, MD is being honored as a Heart of Gold Recognition Award recipient by the Association of Fundraising Professionals (AFP) Big Bend Chapter for his notable efforts to benefit the Tallahassee community.
Florida Cancer Specialists & Research Institute (FCS) welcomes Board-certified medical oncologist Ke Ning, MD to the Sarasota Downtown clinic team. Dr. Ning joined the statewide practice in 2020 and has been serving as a hospitalist in the Sarasota community.
A study conducted by Florida Cancer Specialists & Research Institute, LLC (FCS) evaluating the use of a new therapy to improve chemotherapy treatment outcomes was published in the October issue of the International Journal of Cancer Care and Delivery.
FCS Top News Updates
FCS Expands Footprint Into St. Lucie County, Breaks Ground For New Cancer Center in Tradition
FCS Welcomes Senior Leaders to Finance TeamFlorida Cancer Specialists & Research Institute, LLC (FCS) is pleased to welcome two experienced senior leaders to its Finance team – Christopher Jenkins, Vice President of Financial Planning & Analysis and Tara Lambert, Vice President & Controller, Accounting.
FCS Supports American Cancer Society Guidelines for ColonoscopiesFCS takes exception to a recent study published suggesting that colonoscopies are not as effective at preventing colorectal cancer deaths as previously thought.
FCS: Pioneering Prostate Cancer TreatmentAt FCS, we offer all the available treatments for prostate cancer including radiation therapy, robotic radical prostatectomy and cryoablation.
Florida Cancer Specialists & Research Institute Celebrates Opening Of New Clinic Site in Polk CountyFlorida Cancer Specialists & Research Institute, LLC (FCS) celebrated the groundbreaking for its new clinical site location in Davenport, FL, yesterday. The new clinic will be located at 2050 Holly Hill Fruit Rd., Davenport, FL. 33837, and will boast nearly 15,000 square feet and offer a broad range of treatments and services for patients with cancer and blood disorders, including medical oncology/hematology, infusions, radiology, an in-house laboratory and pharmacy, and care management services.
Scott Tetreault, MD Receives Heart of Gold Recognition From Association of Fundraising Professionals in Big Bend RegionFlorida Cancer Specialists & Research Institute, LLC (FCS) medical oncologist Scott Tetreault, MD is being honored as a Heart of Gold Recognition Award recipient by the Association of Fundraising Professionals (AFP) Big Bend Chapter for his notable efforts to benefit the Tallahassee community.
Bone Mineral Density a Concern for Common Prostate Cancer TherapyDiane Cope, PhD evaluates the bone health of men with prostate cancer undergoing androgen deprivation therapy.
Medical Oncologist Ke Ning, MD Joins Florida Cancer Specialists & Research Institute Sarasota Downtown ClinicFlorida Cancer Specialists & Research Institute (FCS) welcomes Board-certified medical oncologist Ke Ning, MD to the Sarasota Downtown clinic team. Dr. Ning joined the statewide practice in 2020 and has been serving as a hospitalist in the Sarasota community.
Study Conducted by FCS Finds New Therapy May Improve Treatment Outcomes For Patients with Extensive-Stage Small Cell Lung CancerA study conducted by Florida Cancer Specialists & Research Institute, LLC (FCS) evaluating the use of a new therapy to improve chemotherapy treatment outcomes was published in the October issue of the International Journal of Cancer Care and Delivery.